A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation.

Systemic lupus erythematosus (SLE) has higher incidence and mortality rates in addition to a greater risk for nephropathy in African Americans (blacks), compared with whites. We analyzed the South-Eastern Organ Procurement Foundation (SEOPF) database from 1982 through 1986 to determine if variation in human leukocyte antigen (HLA) frequencies, beyond those normally present between the races, were associated with lupus nephritis (LN). HLA antigen frequencies in 271 black and 230 white renal transplant recipients with LN as the cause of end-stage renal disease (ESRD) were compared with 4,506 race-matched cadaveric kidney donor controls. Odds ratios (ORs) and chi-square values were computed to assess the prevalence of each HLA phenotype among the cases versus the controls separately for blacks and whites. HLA-B8 and -DR2 frequencies were increased, and HLA-DR4 frequency was decreased in cases of both races compared with race-matched controls (race-combined ORs, 1.68, 1.46, and 0.49, respectively; all P < 0.01). Race-specific analyses showed that HLA-DR6 was decreased in black cases versus black controls (OR, 0.48; P < 0.001) and HLA-DR3 was increased in white cases versus white controls (OR, 1.88; P < 0.001). HLA-B8 and DR2 are positively associated and HLA-DR4 is negatively associated with LN in patients of both races. HLA-DR3 and -DR6 demonstrate race-specificity in LN and place whites at a disadvantage relative to blacks. It is likely that non-HLA-mediated genetic factors and/or environmental factors contribute to the increased risk of nephritis observed in black patients with SLE.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  M. Walport,et al.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. , 1983, British medical journal.

[2]  J. Bodmer,et al.  Nomenclature for factors of the HLA system, 1991 , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[3]  J. Evans,et al.  Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation. , 1993, Journal of the American Society of Nephrology : JASN.

[4]  M. Pfeifer,et al.  Risk for Cardiovascular Autonomic Neuropathy Is Associated with the HLA-DR3/4 Phenotype in Type I Diabetes Mellitus , 1992, Annals of Internal Medicine.

[5]  P. Schur,et al.  Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. , 1982, Clinical immunology and immunopathology.

[6]  R. E. Boyd,et al.  Systemic Lupus Erythematosus: A Review of Clinico‐Laboratory Features and Immunogenetic Markers in 150 Patients with Emphasis on Demographic Subsets , 1985, Medicine.

[7]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .

[8]  F. Arnett,et al.  STUDIES IN FAMILIAL SYSTEMIC LUPUS ERYTHEMATOSUS , 1976, Medicine.

[9]  H. Mcdevitt,et al.  Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. , 1990, Arthritis and rheumatism.

[10]  Stanley L. Lee,et al.  The epidemiology of systemic lupus erythematosus. , 1973, Seminars in arthritis and rheumatism.

[11]  E. Scopelitis,et al.  Association of HLA-DR7 with both antibody to SSA(Ro) and disease susceptibility in blacks with systemic lupus erythematosus. , 1984, The Journal of rheumatology.

[12]  M. Espeland,et al.  Racial differences in HLA antigen frequency and hypertensive renal failure. , 1991, American journal of hypertension.

[13]  R. Schwartz,et al.  Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. , 1979, The New England journal of medicine.

[14]  J G Bodmer,et al.  Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. , 1971, The New England journal of medicine.

[15]  G. Hughes,et al.  Survival in systemic lupus erythematosus. , 1988, British journal of hospital medicine.

[16]  M. Lockshin,et al.  Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. , 1975, The American journal of medicine.

[17]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[18]  S. Ballou,et al.  Clinical features of systemic lupus erythematosus: differences related to race and age of onset. , 1982, Arthritis and rheumatism.

[19]  S. Studenski,et al.  Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. , 1987, Arthritis and rheumatism.

[20]  J. Brown,et al.  Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). , 1974, Arthritis and rheumatism.

[21]  A. Masi,et al.  Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. , 1978, Arthritis and rheumatism.

[22]  J. Reveille,et al.  Prognosis in systemic lupus erythematosus , 1990 .

[23]  M. Hochberg,et al.  The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. , 1985, Arthritis and rheumatism.

[24]  P. Schur,et al.  The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. , 1990, Arthritis and rheumatism.

[25]  J. Fries,et al.  A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. , 1982, Arthritis and rheumatism.

[26]  Callender Co Organ donation in the black population: where do we go from here? , 1987 .

[27]  C Anasetti,et al.  Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors. , 1993, Transplantation proceedings.

[28]  J. Reveille,et al.  DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[29]  M. Hochberg,et al.  Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. , 1986, The American journal of medicine.

[30]  P. Terasaki,et al.  HLA and Disease Associations , 1985, Springer New York.

[31]  P. Schneider,et al.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. , 1992, The Journal of clinical investigation.

[32]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[33]  J. Bodmer,et al.  Nomenclature for Factors of the HLA System, 1991 , 1992, Immunobiology.